Coronavirus Live Updates: Tracking the Race for a Vaccine

Coronavirus Live Updates: Tracking the Race for a Vaccine


In the worldwide race for a vaccine, here’s where they stand.

Researchers around the world are developing more than 125 vaccines against the coronavirus. Vaccines typically require years of research and testing before reaching the clinic, but scientists are hoping to produce a safe and effective vaccine by next year.

The New York Times is following the status of those that have reached trials in humans.

There are three phases before a vaccine is approved for use, but some projects have combined early phase trials to speed up the process. Some coronavirus vaccines are now in Phase I/II trials, for example, in which they are tested for the first time on hundreds of people.

Additionally, the U.S. government’s Operation Warp Speed program has selected five vaccine projects to receive billions of dollars in federal funding and support before there’s proof that the vaccines work.

There has not yet been a significant public debate over South Korea’s new tracking system, although that may come as the government rolls it out.

Since last month, South Korea has eased its social-distancing restrictions, saying it was confident in its virus-containment strategy. But it has also urged people to stick to preventive measures and said its goal is to keep the daily caseload below 50 until a vaccine is available.

South Korea’s daily caseload has fluctuated between 38 and 57 over the past week, and the country reported 50 new cases on Wednesday.

Here are other developments from around the world:

Mnuchin plans to paint an optimistic picture of the economy’s trajectory.



Source link

Leave a Reply